USPTO serial 78135887
DETECT. DISCOVER. IDENTIFY.
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- TAYLOR, DAVID T
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with DETECT. DISCOVER. IDENTIFY.?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David Farah
DAVID FARAH SHELDON & MAK225 S LAKE AVE 9TH FLPASADENA, CA 91101UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | COMPUTER SOFTWARE FOR ANALYZING, DETECTING, QUANTIFYING AND SEQUENCING POLYPEPTIDES AND POLYNUCLEOTIDES, INCLUDING POLYPEPTIDE VARIANTS, POLYNUCLEOTIDE VARIANTS, GENETIC MUTATIONS, SINGLE NUCLEOTIDE POLYMORPHISMS, HAPLOTYES AND HETEROZYGOSITY FOR USE IN GENETIC, MEDICAL AND SCIENTIFIC ANALYSIS AND RESEARCH, AND FOR USE IN IDENTIFYING DISEASES | ACTIVE | — |
| 042 | RESEARCH AND DEVELOPMENT OF NEW PRODUCTS FOR OTHERS IN THE NATURE OF DESIGNING BIOLOGICAL MOLECULES, INCLUDING POLYNUCLEOTIDES, POLYPEPTIDES AND VECTORS; CHEMICAL ANALYSIS SERVICES IN THE NATURE OF EVALUATING BIOLOGICAL MOLECULES, INCLUDING POLYNUCLEOTIDES, POLYPEPTIDES AND VECTORS; RESEARCH AND DEVELOPMENT OF NEW PRODUCTS FOR OTHERS, NAMELY, SERVICES PRODUCING BIOLOGICAL MOLECULES, INCLUDING POLYNUCLEOTIDES, POLYPEPTIDES AND VECTORS; PHARMACEUTICAL DRUG DEVELOPMENT SERVICES FOR OTHERS; CHEMICAL ANALYSIS AND SCIENTIFIC RESEARCH SERVICES IN THE FIELD OF DRUG DEVELOPMENT, NAMELY EVALUATING THE ACTIVITY OF DRUGS AND CANDIDATE SUBSTANCES FOR DRUGS FOR OTHERS | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BioVentures, Incorporated
- Other trademarks owned by BioVentures, Incorporated
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named DETECT. DISCOVER. IDENTIFY.
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 4, 2006 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 4, 2006 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 29, 2005 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Mar 29, 2005 | EXT4 | SOU EXTENSION 4 FILED | — |
| Mar 29, 2005 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 6, 2004 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Sep 30, 2004 | EXT3 | SOU EXTENSION 3 FILED | — |
| Sep 30, 2004 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 7, 2004 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 5, 2004 | CFIT | CASE FILE IN TICRS | — |
| Apr 28, 2004 | EXT2 | SOU EXTENSION 2 FILED | — |
| Apr 28, 2004 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 6, 2003 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 29, 2003 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 29, 2003 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 29, 2003 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 4, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 15, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 2, 2002 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 22, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 27, 2002 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 27, 2002 | DOCK | ASSIGNED TO EXAMINER | — |